Treatment Outcomes with Standard of Care in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Real-World Data Analysis

被引：0
|
作者：
Andrew Ip
Alex Mutebi
Tongsheng Wang
Monika Jun
Anupama Kalsekar
Fernando Rivas Navarro
Anthony Wang
Rajesh Kamalakar
Mariana Sacchi
Brian Elliott
机构：
[1] Hackensack University Medical Center,Hackensack Meridian Health
[2] Genmab US,undefined
[3] Inc.,undefined
[4] AbbVie,undefined
[5] Inc.,undefined
来源：
Advances in Therapy | 2024年 / 41卷
关键词：
Bispecific antibody; Chimeric antigen receptor; Immunotherapy; Observational; Real-world evidence; Retrospective; Salvage therapy; Standard of care;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1226 / 1244
页数：18
相关论文
共 50 条
  • [1] Treatment Outcomes with Standard of Care in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Real-World Data Analysis
    Ip, Andrew
    Mutebi, Alex
    Wang, Tongsheng
    Jun, Monika
    Kalsekar, Anupama
    Navarro, Fernando Rivas
    Wang, Anthony
    Kamalakar, Rajesh
    Sacchi, Mariana
    Elliott, Brian
    [J]. ADVANCES IN THERAPY, 2024, 41 (03) : 1226 - 1244
  • [2] Real-World Outcomes in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with Standard of Care: A Cota Database Analysis
    Ip, Andrew
    Mutebi, Alex
    Wang, Tongsheng
    Jun, Monika P.
    Kalsekar, Anupama
    Navarro, Fernando Rivas
    Wang, Anthony
    Kamalakar, Rajesh
    Sacchi, Mariana
    Elliott, Brian
    [J]. BLOOD, 2022, 140 : 6693 - 6694
  • [3] Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data
    Atesoglu, Elif Birtas
    Gulbas, Zafer
    Uzay, Ant
    Ozcan, Muhit
    Ozkalemkas, Fahir
    Dal, Mehmet Sinan
    Kalyon, Hakan
    Akay, Olga Meltem
    Deveci, Burak
    Bekoz, Huseyin
    Sevindik, Omur Gokmen
    Toptas, Tayfur
    Yilmaz, Fergun
    Koyun, Derya
    Alkis, Nihan
    Alacacioglu, Inci
    Sonmez, Mehmet
    Yavasoglu, Irfan
    Tombak, Anil
    Mehtap, Ozgur
    Kurnaz, Fatih
    Yuce, Orhan Kemal
    Karakus, Volkan
    Turgut, Mehmet
    Kurekci, Derya Deniz
    Ayer, Mesut
    Keklik, Muzaffer
    Buyuktas, Deram
    Ozbalak, Murat
    Ferhanoglu, Burhan
    [J]. HEMATOLOGICAL ONCOLOGY, 2023, 41 (04) : 663 - 673
  • [4] Real-world outcomes with novel therapies in relapsed/refractory diffuse large B-cell lymphoma
    Crombie, Jennifer L.
    Jun, Monika
    Wang, Tongsheng
    Mutebi, Alex
    Wang, Anthony
    Chhibber, Anindit
    Kamalakar, Rajesh
    Ukropec, Jon
    Blaedel, Julie
    Kalsekar, Anupama
    [J]. LEUKEMIA & LYMPHOMA, 2024,
  • [5] Real-world practice patterns and outcomes in Veterans with relapsed/refractory diffuse large B-cell lymphoma
    Chien, Hsu-Chih
    Morreall, Deborah
    Patil, Vikas
    Rasmussen, Kelli M.
    Li, Chungyang
    Yong, Christina M.
    Burningham, Zachary
    Masaquel, Anthony
    Halloran, Mary
    De Long-Sieg, Elisha
    Schulz, Mathias
    Sauer, Brian C.
    Halwani, Ahmad S.
    [J]. FUTURE ONCOLOGY, 2020, 17 (04) : 411 - 422
  • [6] Real-world total cost of care by line of therapy in relapsed/refractory diffuse large B-cell lymphoma
    Gatwood, Justin
    Masaquel, Anthony
    Fox, David
    Sheinson, Daniel
    James, Cameron
    Li, Jia
    Hossain, Farah
    Ross, Ryan
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 738 - 745
  • [7] REAL-WORLD TREATMENT PATTERNS AND COSTS IN RELAPSED AND REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE UNITED STATES
    Mutebi, A.
    Jun, M.
    Flores, C.
    Wang, Z.
    Wang, A.
    Elliot, B.
    Navarro, F. R.
    Kalsekar, A.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S394 - S394
  • [8] Real-World Evidence of Tisagenlecleucel for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma
    Iacoboni, Gloria
    Iraola-Truchuelo, Josu
    Martinez-Cibrian, Nuria
    Bailen, Rebeca
    Corral, Lucia Lopez
    Sanchez, Jose M.
    Gonzalez, Ana Carolina Carolina Caballero
    Mussetti, Alberto
    Sancho, Juan-Manuel
    Hernani, Rafael
    Solano, Carlos
    Balari, Anna Sureda
    Briones, Javier
    Garcia-Sancho, Alejandro Martin
    Kwon, Mi
    Reguera, Juan Luis
    Barba, Pere
    [J]. BLOOD, 2020, 136
  • [9] Real-world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B-cell lymphoma
    Iacoboni, Gloria
    Villacampa, Guillermo
    Martinez-Cibrian, Nuria
    Bailen, Rebeca
    Lopez Corral, Lucia
    Sanchez, Jose M.
    Guerreiro, Manuel
    Carolina Caballero, Ana
    Mussetti, Alberto
    Sancho, Juan-Manuel
    Hernani, Rafael
    Abrisqueta, Pau
    Solano, Carlos
    Sureda, Anna
    Briones, Javier
    Martin Garcia-Sancho, Alejandro
    Kwon, Mi
    Luis Reguera-Ortega, Juan
    Barba, Pere
    [J]. CANCER MEDICINE, 2021, 10 (10): : 3214 - 3223
  • [10] Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy
    Argnani, Lisa
    Broccoli, Alessandro
    Pellegrini, Cinzia
    Fabbri, Alberto
    Puccini, Benedetta
    Bruna, Riccardo
    Tisi, Maria Chiara
    Masia, Francesco
    Flenghi, Leonardo
    Nizzoli, Maria Elena
    Musso, Maurizio
    Salerno, Marilena
    Scalzulli, Potito Rosario
    Dessi', Daniela
    Ferrarini, Isacco
    Pennese, Elsa
    Lucchini, Elisa
    Rossi, Francesca Gaia
    Minoia, Carla
    Gherlinzoni, Filippo
    Musto, Pellegrino
    Patti, Caterina
    Stefoni, Vittorio
    Zinzani, Pier Luigi
    [J]. HEMASPHERE, 2022, 6 (12):
12345